Infectious diseases are commonly implicated as potential initiators of autoimmune diseases
(ADs) and represent the most commonly known factor in the development of autoimmunity in …

With the ability to induce T cell activation and elicit humoral responses, B cells are generally
considered as effectors of the immune system. However, the emergence of regulatory B cells …

Convalescent plasma (CP) has emerged as a treatment for COVID-19. However, the
composition and mechanism of action are not fully known. Therefore, we undertook a two …

Autoimmune responses mediated by autoantibodies have been observed in SARS-CoV-2
infection. Herein, we evaluate the presence of rheumatic, thyroid and phospholipid …

Objective Patients with hypothyroidism due to Hashimoto's disease (HD) may experience
persisting symptoms despite normal serum thyroid hormone (TH) levels. Several hypotheses …

Objective The clinical coexistence of two or more autoimmune diseases (ADs) fulfilling
classification criteria is termed “overt polyautoimmunity”(PolyA), whereas the presence of …

Objective To analyze whether immune-mediated diseases (IMDs) occurs in sarcoidosis
more commonly than expected in the general population, and how concomitant IMDs …

Autoimmune diseases (ADs) have a common pathophysiological mechanism as a
consequence of sharing genetic and environmental factors, as well as similar clinical …

Osteoarthritis is the most prevalent age-related degenerative joint disease and a leading
cause of pain and disability in aged people. Its etiology is multifaceted, involving factors …

Data regarding the in-depth surface marker profiles of gastric tissue-resident lymphocytes in
autoimmune and Helicobacter pylori-associated gastritis are lacking. In this study, we …